| Literature DB >> 31097997 |
Lijie Peng1, Zhensheng Zhang1, Chong Lei1, Shan Li1, Zhang Zhang1, Xiaomei Ren1, Yu Chang1, Yan Zhang2, Yong Xu2, Ke Ding1.
Abstract
A series of (E)-3-(4-((2,4-bis(trifluoromethyl)benzyl)oxy)-3-methoxyphenyl)-2-cyanoacrylamide derivatives were designed and synthesized as new estrogen-related receptor α (ERRα) degraders based on the proteolysis targeting chimera (PROTAC) concept. One of the representative compounds 6c is capable of specifically degrading ERRα protein by >80% at a relatively low concentration of 30 nM, becoming one of the most potent and selective ERRα degraders to date. Compound 6c could be utilized as a new powerful research tool for further biological investigation of ERRα.Entities:
Year: 2019 PMID: 31097997 PMCID: PMC6512006 DOI: 10.1021/acsmedchemlett.9b00025
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345